Epigenetic repression of E-cadherin expression by hepatitis B virus x antigen in liver cancer

Oncogene

Volumn 31, Issue 5, 2012, Pages 563-572

  Arzumanyan, A ^a   Friedman, T ^a   Kotei, E ^a   Ng, I O L ^b   Lian, Z ^a   Feitelson, M A ^a  

^a Temple University   (United States)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

HDAC; hepatocellular carcinoma; miR 373; mSin3A; Snail 1

Indexed keywords

HEPATITIS B VIRUS X PROTEIN; HISTONE DEACETYLASE; MICRORNA; TRANSCRIPTION FACTOR SIN3A; TRANSCRIPTION FACTOR SNAIL; UVOMORULIN;

ADULT; AGED; ARTICLE; DEACETYLATION; DNA METHYLATION; DOWN REGULATION; EPIGENETICS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CANCER; MALE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; TRANSCRIPTION REGULATION; VIRUS CARCINOGENESIS;

ADULT; AGED; BLOTTING, WESTERN; CADHERINS; CELLS, CULTURED; CHROMATIN IMMUNOPRECIPITATION; DNA METHYLATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEP G2 CELLS; HEPATOCYTES; HUMANS; LIVER; LIVER NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; REPRESSOR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS;

GASTROPODA; HEPATITIS B VIRUS;

EID: 84856528807     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2011.255     Document Type: Article

References (55)

1. Agami R. (2010). Micro-RNAs, RNA binding proteins and cancer. Eur J Clin Invest 40: 370-374.
2. Batlle E, Sancho E, Francí C, Domínguez D, Monfar M, Baulida J et al. (2000). The transcription factor Snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol 2: 84-89.
3. Cameron EE, Bachman KE, Myohanen S, Herman JG, Baylin SB. (1999). Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nat Genet 21: 103-107. (Pubitemid 29036293)
4. Chung TW, Lee YC, Kim CH. (2004). Hepatitis B viral HBx induces MMP-9 gene expression through activation of ERK and PI-3K/AKT pathways: involvement of invasive potential. FASEB J 18: 1123-1125.
5. Endo K, Ueda T, Ueyama J, Ohta T, Terada T. (2000). Immunoreactive E-cadherin, alpha-catenin, beta-catenin, and gamma-catenin proteins in hepatocellular carcinoma: relationships with tumor grade, clinicopathological parameters, and patients' survival. Hum Pathol 31: 558-565.
6. Feitelson MA,Millman I, Duncan GD, Blumberg BS. (1988). Presence of antibodies to the polymerase gene product(s) of hepatitis B and woodchuck hepatitis virus in natural and experimental infections. J Med Virol 24: 121-136. (Pubitemid 18082780)
7. Giroldi L, Bringuier P, de Weijert M, Jansen C, van Bokhoven A, Schalken JA. (1997). Role of E boxes in the repression of E-cadherin expression. Biochem Biophys Res Commun 241: 453-458. (Pubitemid 28020121)
8. Guarino M, Rubino B, Ballabio G. (2007). The role of epithelialmesenchymal transition in cancer pathology. Pathology 39: 305-318. (Pubitemid 46897605)
9. Haviv I, Vaizel D, Shaul Y. (1996). pX, the HBV-encoded coactivator, interacts with components of the transcription machinery and stimulates transcription in a TAF-independent manner. EMBO J 15: 3413-3420. (Pubitemid 26231948)
10. He L, Hannon GJ. (2004). Micro-RNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 5: 522-531. (Pubitemid 38868508)
11. Hirohashi S, Kanai Y. (2003). Cell adhesion system and human cancer morphogenesis. Cancer Sci 94: 575-581. (Pubitemid 36975010)
12. Iwatsuki M, Mimori K, Yokobori T, Ishi H, Beppu T, Nakamori S et al. (2009). Epithelial-mesenchymal transition in cancer development and its clinical significance. Cancer Sci 101: 293-299.
13. Janowski BA, Younger ST, Hardy DB, Ram R, Huffman KE, Corey DR. (2007). Activating gene expression in mammalian cells with promoter-targeted duplex RNAs. Nat Chem Biol 3: 166-173.
14. Jiao W, Miyazaki K, Kitajima Y. (2002). Inverse correlation between E-cadherin and Snail expression in hepatocellular carcinoma cell lines in vitro and in vivo. Br J Cancer 86: 98-101. (Pubitemid 34146348)
15. Kanai Y, Ushijima S, Hui AM, Ochiai A, Tsuda H, SakamotoM et al. (1997). The E-cadherin gene is silenced by CpG methylation in human hepatocellular carcinomas. Int J Cancer 71: 355-359. (Pubitemid 27224296)
16. Keasler VV, Hodgson AJ, Madden CR, Slagle BL. (2009). Hepatitis B virus HBx protein localized to the nucleus restores HBx-deficient virus replication in HepG2 cells and in vivo in hydrodynamicallyinjected mice. Virology 390: 122-129.
17. Kekule AS, Lauer U, Weiss L, Luber B, Hofschneider PH. (1993). Hepatitis B virus trans-activator HBx uses a tumour promoter signaling pathway. Nature 361: 742-745. (Pubitemid 23070485)
18. Lee DK, Park SH, Yi Y, Choi SG, Lee C, Parks WT et al. (2001). The hepatitis B virus encoded oncoprotein pX amplifies TGF-beta family signaling through direct interaction with Smad4: potential mechanism of HBV-induced liver fibrosis. Genes Dev 15: 455-466. (Pubitemid 32187006)
19. Lee JO, Kwun HJ, Jung JK, Choi KH, Min DS, Jang KL. (2005). Hepatitis B virus X protein represses E-cadherin expression via activation of DNA methyltransferase 1. Oncogene 24: 6617-6625. (Pubitemid 41486792)
20. Li LC, Okino ST, Zhao H, Pookot D, Place RF, Urakami S et al. (2006). Small dsRNAs induce transcriptional activation in human cells. Proc Natl Acad Sci USA 103: 17337-17342. (Pubitemid 44788970)
21. Lian Z, Liu J, Li L, Li X, Clayton M, Wu MC et al. (2006). Enhanced cell survival of Hep3B cells by the hepatitis B x antigen effector, URG11, is associated with upregulation of beta-catenin. Hepatology 43: 415-424.
22. Lian Z, Pan J, Liu J, Zhang S, Zhu M, Arbuthnot P et al. (1999). The translation initiation factor, hu-Sui1 may be a target of hepatitis B X antigen in hepatocarcinogenesis. Oncogene 18: 1677-1587.
23. Liu J, Lian Z, Han S, Waye MM, Wang H, Wu MC et al. (2006). Downregulation of E-cadherin by hepatitis B virus X antigen in hepatocellullar carcinoma. Oncogene 25: 1008-1017. (Pubitemid 43277009)
24. Lupberger J, Hildt E. (2007). Hepatitis B virus-induced oncogenesis. World J Gastroenterol 13: 74-81. (Pubitemid 46165464)
25. MacPherson MR, Molina P, Souchelnytskyi S, Wernstedt C, Martin-Pérez J, Portillo F et al. (2010). Phosphorylation of serine 11 and serine 92 as new positive regulators of human Snail1 function: potential involvement of casein kinase-2 and the cAMP-activated protein kinase A. Mol Biol Cell 21: 244-253.
26. Moustakas A, Heldin CH. (2007). Signaling networks guiding epithelial-mesenchymal transitions during embryogenesis and cancer progression. Cancer Sci 98: 1512-1520. (Pubitemid 47308444)
27. Nomura T, Lin Y, Dorjsuren D, Ohno S, Yamashita T, Murakami S et al. (1999). Human hepatitis B virus X protein is detectable in nuclei of transfected cells, and is active for transactivation. Biochim Biophys Acta 1453: 330-340. (Pubitemid 29146157)
28. Osada T, Sakamoto M, Ino Y, Iwamatsu A, Matsuno Y, Muto T et al. (1996). E-cadherin is involved in the intrahepatic metastasis of hepatocellular carcinoma. Hepatology 24: 1460-1467. (Pubitemid 26399050)
29. Ou JN, Torrisani J, Unterberger A, Provençal N, Shikimi K, Karimi Met al. (2007). Histone deacetylase inhibitor Trichostatin A induces global and gene-specific DNA demethylation in human cancer cell lines. Biochem Pharmacol 73: 1297-1307. (Pubitemid 46452588)
30. Pan J, Clayton M, Feitelson MA. (2004). Hepatitis B virus X antigen promotes TGF-beta1 activity by up-regulation of TGF-beta1 and down-regulation of alpha2-macroglobulin. J Gen Virol 85(Part 2): 275-282. (Pubitemid 38262562)
31. Park IY, Sohn BH, Yu E, Suh DJ, Chung YH, Lee JH et al. (2007). Aberrant epigenetic modifications in hepatocarcinogenesis induced by hepatitis B virus X protein. Gastroenterology 132: 1476-1494. (Pubitemid 46627570)
32. Park NH, Song IH, Chung YH. (2006). Chronic hepatitis B in hepatocarcinogenesis. Postgrad Med J 82: 507-515. (Pubitemid 44258625)
33. Peinado H, Ballestar E, Esteller M, Cano A. (2004). Snail mediates Ecadherin repression by the recruitment of the Sin3A/HDAC1/HDAC2 complex. Mol Cell Biol 24: 306-319. (Pubitemid 38010056)
34. Peinado H, Quintanilla M, Cano A. (2003). TGFb-1 induces snail transcription factor in epithelial cell lines: mechanisms for epithelial mesenchymal transitions. J Biol Chem 278: 113-123.
35. Perl AK, Wilgenbus P, Dahl U, Semb H, Christofori G. (1998). A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature 392: 190-193. (Pubitemid 28162793)
36. Place R, Li L, Pookot D, Noonan EJ, Dahiya R. (2008). MicroRNA-373 induces expression of genes with complementary promoter sequences. Proc Natl Acad Sci USA 105: 1608-1613. (Pubitemid 351346562)
37. Rikimaru T, Taketomi A, Yamashita Y, Shirabe K, Hamatsu T, Shimada M et al. (2007). Clinical significance of histone deacetylase 1 expression in patients with hepatocellular carcinoma. Oncology 72: 69-74. (Pubitemid 350249132)
38. Ropero S, Esteller M. (2007). The role of histone deacetylases (HDACs) in human cancer. Mol Oncol 1: 19-25. (Pubitemid 46776612)
39. Shon JK, Shon BH, Park IY, Lee SU, Fa L, Chang KY et al. (2009). Hepatitis B virus-X protein recruits histone deacetylase 1 to repress insulin-like growth factor binding protein 3 transcription. Virus Res 139: 14-21.
40. Sirma H, Weil R, Rosmorduc O, Urban S, Israé l A, Kremsdorf D et al. (1998). Cytosol is the prime compartment of hepatitis B virus X protein where it co-localizes with the proteasome. Oncogene 16: 2051-2063. (Pubitemid 28211680)
41. Sugimachi K, Tanaka S, Kameyama T, Taguchi K, Aishima S, Shimada M et al. (2003). Transcriptional repressor Snail and progression of human hepatocellular carcinoma. Clin Cancer Res 9: 2657-2664. (Pubitemid 36842110)
42. Takeichi M. (1991). Cadherin cell adhesion receptors as a morphogenetic regulator. Science 251: 1451-1455. (Pubitemid 121000430)
43. Takeno S, Noguchi T, Fumoto S, Kimura Y, Shibata T, Kawahara K. (2004). E-cadherin expression in patients with esophageal squamous cell carcinoma: Promoter hypermethylation, Snail overexpression, and clinico-pathologic implications. Am J Clin Pathol 122: 78-84. (Pubitemid 38849875)
44. van Roy F, Berx G. (2008). The cell-cell adhesion molecule E-cadherin. Cell Mol Life Sci 65: 3756-3788.
45. Wadia JS, Stan RV, Dowdy SF. (2004). Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. Nat Med 1: 310-315. (Pubitemid 38667624)
46. Wang W, London WT, Feitelson MA. (1991a). Hepatitis B x antigen in hepatitis B virus carrier patients with liver cancer. Cancer Res 51: 4971-4977.
47. Wang W, London WT, Lega L, Feitelson MA. (1991b). HBxAg in liver from carrier patients with chronic hepatitis and cirrhosis. Hepatology 14: 29-37.
48. Waris G, Huh KW, Siddiqui A. (2001). Mitochondrially associated hepatitis B virus X protein constitutively activates transcription factors STAT-3 and NF-kB via oxidative stress. Mol Cell Biol 21: 7721-7730. (Pubitemid 32988782)
49. Weil R, Sirma H, Giannini C, Kremsdorf D, Bessia C, Dargemont C et al. (1999). Direct association and nuclear import of the hepatitis B virus X protein with the NF-kB inhibitor IkBa. Mol Cell Biol 19: 6345-6354. (Pubitemid 29399339)
50. Xu J, Lamouille S, Derynck R. (2009). TGF-beta-induced epithelial to mesenchymal transition. Cell Res 19: 156-172.
51. Yoo YD, Ueda H, Park K, Flanders KC, Lee YI, Jay G et al. (1996). Regulation of TGF-beta 1 expression by the hepatitis B virus (HBV) X transactivator. Role in HBV pathogenesis. J Clin Invest 97: 388-395.
52. Yoo YG, Na TY, Seo HW, Seong JK, Park CK, Shin YK et al. (2008). Hepatitis B virus X protein induces the expression of MTA1 and HDAC1, which enhances hypoxia signaling in hepatocellular carcinoma cells. Oncogene 27: 3405-3413. (Pubitemid 351769313)
53. Zeng PY, Vakoc CR, Chen ZC, Blobel GA, Berger SL. (2006). In vivo dual cross-linking for identification of indirect DNA-associated proteins by chromatin immunoprecipitation. Biotechniques 41: 694-698. (Pubitemid 46534851)
54. Zheng DL, Zhang L, Cheng N, Xu X, Deng Q, Teng XM et al. (2009). Epigenetic modification induced by hepatitis B virus X protein via interaction with de novo DNA methyltransferase DNMT3A. J Hepatol 50: 377-387.
55. Zhou H, Wu S, Joo JY, Zhu S, Han DW, Lin T et al. (2009). Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell 4: 381-384.